Pathogenetic rationale for the use of cell therapy in lung injury associated with SARS-CoV-2
Acute respiratory disease COVID-19 caused by the SARS-CoV-2 coronavirus demonstrate weak clinical manifestation in most patients. However, pneumonia and acute respiratory distress syndrome in some cases may cause serious problems due to the lack of effective etiotropic and pathogenetic therapy. Pres...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Kubankurortresurs, OOO
2020-06-01
|
| Series: | Инновационная медицина Кубани |
| Subjects: | |
| Online Access: | https://inovmed.elpub.ru/jour/article/view/279 |